<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2431-2-12.anc" start="13150" end="13160" sStart="-1" offset="0" sid="null" wn="2" wnkey="suspicious%5:00:00:questionable:00" text="Reye syndrome, a disorder of unknown cause, is characterized by acute encephalopathy and fatty degeneration of the liver and it is usually characterized by a history of preceding viral illness or the use of aspirin during viral infections [ 10 ] . Many children with metabolic disorders present with Reye-like syndrome episodes, usually at a young age and/or with a positive past or family history &lt;b&gt;suspicious&lt;/b&gt; for an inborn error of metabolism [ 11 ] . It has been reported as a presenting sign of type I 3-MGC aciduria and in a few cases of mitochondrial cytopathies in older children [ 12 13 ] . However in the neonatal period, a Reye-like episode is not a typical presenting feature of a mitochondrial cytopathy." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2431-2-12.anc" start="13150" end="13160" sStart="null" offset="0" sid="null" wn="2" wnkey="suspicious%5:00:00:questionable:00" text="Reye syndrome, a disorder of unknown cause, is characterized by acute encephalopathy and fatty degeneration of the liver and it is usually characterized by a history of preceding viral illness or the use of aspirin during viral infections [ 10 ] . Many children with metabolic disorders present with Reye-like syndrome episodes, usually at a young age and/or with a positive past or family history &lt;b&gt;suspicious&lt;/b&gt; for an inborn error of metabolism [ 11 ] . It has been reported as a presenting sign of type I 3-MGC aciduria and in a few cases of mitochondrial cytopathies in older children [ 12 13 ] . However in the neonatal period, a Reye-like episode is not a typical presenting feature of a mitochondrial cytopathy." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2431-2-12.anc" start="13150" end="13160" sStart="null" offset="0" sid="null" wn="2" wnkey="suspicious%5:00:00:questionable:00" text="Reye syndrome, a disorder of unknown cause, is characterized by acute encephalopathy and fatty degeneration of the liver and it is usually characterized by a history of preceding viral illness or the use of aspirin during viral infections [ 10 ] . Many children with metabolic disorders present with Reye-like syndrome episodes, usually at a young age and/or with a positive past or family history &lt;b&gt;suspicious&lt;/b&gt; for an inborn error of metabolism [ 11 ] . It has been reported as a presenting sign of type I 3-MGC aciduria and in a few cases of mitochondrial cytopathies in older children [ 12 13 ] . However in the neonatal period, a Reye-like episode is not a typical presenting feature of a mitochondrial cytopathy." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2431-2-12.anc" start="13150" end="13160" sStart="null" offset="0" sid="null" wn="2" wnkey="suspicious%5:00:00:questionable:00" text="Reye syndrome, a disorder of unknown cause, is characterized by acute encephalopathy and fatty degeneration of the liver and it is usually characterized by a history of preceding viral illness or the use of aspirin during viral infections [ 10 ] . Many children with metabolic disorders present with Reye-like syndrome episodes, usually at a young age and/or with a positive past or family history &lt;b&gt;suspicious&lt;/b&gt; for an inborn error of metabolism [ 11 ] . It has been reported as a presenting sign of type I 3-MGC aciduria and in a few cases of mitochondrial cytopathies in older children [ 12 13 ] . However in the neonatal period, a Reye-like episode is not a typical presenting feature of a mitochondrial cytopathy." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="22413" end="22420" sStart="null" offset="117" sid="r8.suggest.v.0292" wn="3" wnkey="suggest%2:32:02::" text="The presence of mild increase in the urinary excretion of orotic acid in this patient could also suggest mitochondrial dysfunction, convalidating this hypothesis." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="16851" end="16857" sStart="null" offset="461" sid="r11.severe.j.0367" wn="1" wnkey="severe%5:00:00:intense:00" text="5) [ 20 ] ; type III 3-MGC aciduria (Costeff optic atrophy syndrome) (Mendelian Inheritance in Man database *258501) was described in patients of Iraqi-Jewish origin with bilateral optic atrophy accompanied in some by movement disorders and caused by mutations in the OPA3 gene [ 21 22 ] ; and type IV 3-MGC aciduria (Mendelian Inheritance in Man database *250951) presents with moderate to severe neurological disease, cardiac, ophthalmic, hepatic, and renal symptoms and it has been associated with mitochondrial disorders (Pearson syndrome, mitochondrial DNA depletion) or multiple respiratory chain defects [ 23 24 25 26 ] . This group does not have a defined primary biochemical or molecular defect." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="2258" end="2264" sStart="null" offset="290" sid="r9.normal.j.0415" wn="3" wnkey="normal%3:00:03::" text="She had an elevated ammonia level of 357 ?mol/L (normal range: 22-48), lactic acid of 10 mmol/l (normal range: 0.2-2), elevated transaminases with an alanine aminotransferase of 69 U/L (normal range: 10-25), an aspartate aminotransferase of 162 U/L (normal range: 15-50), and hypothermia with deteriorating neurological condition." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="3683" end="3689" sStart="null" offset="201" sid="r9.normal.j.0399" wn="3" wnkey="normal%3:00:03::" text="Quantitative analysis of urine organic acids by gas chromatography/mass spectrometry exhibited elevated levels of 3-methylglutaconic (3-MGC) acid of 121 mmol/mol of creatinine (normal range:0-8) and 3-methylglutaric (3-MGR) acid of 33 mmol/mol of creatinine (normal range:0-2) with a normal level of 3-hydroxyisovaleric acid of 40 mmol/mol of creatinine (normal range:0-39) making the diagnosis of type I 3-MGC aciduria less likely." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="3885" end="3891" sStart="null" offset="403" sid="r9.normal.j.0868" wn="1" wnkey="normal%3:00:01::" text="Quantitative analysis of urine organic acids by gas chromatography/mass spectrometry exhibited elevated levels of 3-methylglutaconic (3-MGC) acid of 121 mmol/mol of creatinine (normal range:0-8) and 3-methylglutaric (3-MGR) acid of 33 mmol/mol of creatinine (normal range:0-2) with a normal level of 3-hydroxyisovaleric acid of 40 mmol/mol of creatinine (normal range:0-39) making the diagnosis of type I 3-MGC aciduria less likely." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="2025" end="2031" sStart="null" offset="57" sid="r9.normal.j.0304" wn="1" wnkey="normal%3:00:01::" text="She had an elevated ammonia level of 357 ?mol/L (normal range: 22-48), lactic acid of 10 mmol/l (normal range: 0.2-2), elevated transaminases with an alanine aminotransferase of 69 U/L (normal range: 10-25), an aspartate aminotransferase of 162 U/L (normal range: 15-50), and hypothermia with deteriorating neurological condition." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="2081" end="2087" sStart="null" offset="113" sid="r9.normal.j.0288" wn="1" wnkey="normal%3:00:01::" text="She had an elevated ammonia level of 357 ?mol/L (normal range: 22-48), lactic acid of 10 mmol/l (normal range: 0.2-2), elevated transaminases with an alanine aminotransferase of 69 U/L (normal range: 10-25), an aspartate aminotransferase of 162 U/L (normal range: 15-50), and hypothermia with deteriorating neurological condition." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="10338" end="10344" sStart="null" offset="97" sid="r9.normal.j.0910" wn="2" wnkey="normal%3:00:02::" text="The activity of the mitochondrial respiratory chain enzymes, although mostly below the normal mean, was within the normal range in skeletal muscle with moderate increase (52%) in the activity of citrate synthase suggesting mitochondrial proliferation (Table 1)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="2879" end="2885" sStart="null" offset="33" sid="r9.normal.j.0906" wn="2" wnkey="normal%3:00:02::" text="Brain MRI was reportedly normal." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="10376" end="10382" sStart="null" offset="135" sid="r9.normal.j.0410" wn="2" wnkey="normal%3:00:02::" text="The activity of the mitochondrial respiratory chain enzymes, although mostly below the normal mean, was within the normal range in skeletal muscle with moderate increase (52%) in the activity of citrate synthase suggesting mitochondrial proliferation (Table 1)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2431-2-12.anc" start="20416" end="20420" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="The insertion of 5 C's results in a &lt;b&gt;long&lt;/b&gt; polyC tract." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2431-2-12.anc" start="14529" end="14533" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="In 24 children with inherited disorders of fatty acid oxidation, conduction defects or arrhythmias were the predominant presenting feature [ 14 ] . Arrhythmias in association with hepatomuscular symptoms and hyperammonemia have also been demonstrated in cases of carnitine-acylcarnitine translocase deficiency whose presenting features also include neonatal distress, convulsions, hypoglycemia, hypoketonemia, intermittent dicarboxylic aciduria, hypothermia, apnea, neurological deterioration, and hypocarnitinemia with grossly elevated acylcarnitines [ 15 ] . The accumulation of arrhythmogenic metabolites of fatty acids, such as &lt;b&gt;long&lt;/b&gt; chain acylcarnitines, may be responsible for the observed lethal cardiac defects." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2431-2-12.anc" start="20416" end="20420" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="The insertion of 5 C's results in a &lt;b&gt;long&lt;/b&gt; polyC tract." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2431-2-12.anc" start="14529" end="14533" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="In 24 children with inherited disorders of fatty acid oxidation, conduction defects or arrhythmias were the predominant presenting feature [ 14 ] . Arrhythmias in association with hepatomuscular symptoms and hyperammonemia have also been demonstrated in cases of carnitine-acylcarnitine translocase deficiency whose presenting features also include neonatal distress, convulsions, hypoglycemia, hypoketonemia, intermittent dicarboxylic aciduria, hypothermia, apnea, neurological deterioration, and hypocarnitinemia with grossly elevated acylcarnitines [ 15 ] . The accumulation of arrhythmogenic metabolites of fatty acids, such as &lt;b&gt;long&lt;/b&gt; chain acylcarnitines, may be responsible for the observed lethal cardiac defects." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2431-2-12.anc" start="20174" end="20179" sStart="null" offset="0" sid="null" wn="3" wnkey="know%2:31:02::" text="The A189G has been reported as a polymorphism in Mitomap database [ 34 ] . Whether this alteration would affect mtDNA replication or transcription is not &lt;b&gt;known&lt;/b&gt;." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="5310" end="5314" sStart="null" offset="8" sid="r9.full.j.1000" wn="2" wnkey="full%5:00:01:whole:00" text="Once on full feeds, a trial off sodium benzoate, sodium phenylacetate, and arginine resulted in maintenance of her ammonium levels below 100 ?mol/L." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="5528" end="5532" sStart="null" offset="61" sid="r9.full.j.0686" wn="2" wnkey="full%5:00:01:whole:00" text="The patient was discharged at sixteen days of age on full breast milk feeds, and a ?-blocker." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="11762" end="11767" sStart="null" offset="26" sid="r10.find.v.0735" wn="8" wnkey="find%2:36:00::" text="An obvious difference was found in the D-loop region where A189G was present in the proband in a near homoplasmic state and homoplasmic wild type A189 was present in the proband's mother." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="19018" end="19023" sStart="null" offset="63" sid="r10.find.v.0643" wn="8" wnkey="find%2:36:00::" text="Since no primary deleterious mtDNA mutation has been found in the proband and she was born to healthy parents with unremarkable family history, we hypothesize that the etiology of her mitochondrial dysfunction could reside in a still unidentified nuclear gene defect; although secondary mitochondrial dysfunction caused by an unknown inborn error of metabolism cannot be excluded completely." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2431-2-12.anc" start="7369" end="7377" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="At seven years of age, she has exhibited fatigue, &lt;b&gt;exercise&lt;/b&gt; intolerance and palpitations as the main features of abnormal mitochondrial energy metabolism." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2431-2-12.anc" start="7369" end="7377" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="At seven years of age, she has exhibited fatigue, &lt;b&gt;exercise&lt;/b&gt; intolerance and palpitations as the main features of abnormal mitochondrial energy metabolism." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="9775" end="9784" sStart="null" offset="413" sid="r8.1.different.j.0861" wn="1" wnkey="different%3:00:00::" text="Quantitative evaluation of mtDNA content was performed in skeletal muscle by Southern blot and Real Time quantitative PCR analyses [ 9 ] . To look for unknown mtDNA mutations, the entire mitochondrial genome was screened by temporal temperature gel electrophoresis (TTGE) on mother/child pair, followed by sequencing of the DNA fragments that exhibited different banding patterns between mother and child." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="10673" end="10679" sStart="null" offset="6" sid="r10.common.j.0253" wn="1" wnkey="common%3:00:02::" text="MtDNA common point mutations (MELAS A3243G and T3271C, MERRF A8344G and T8356C, NARP T8993G and T8993C, cardiomyopathy G8363A, and LHON G11778A, G3460A, T14484C, and G14459A), deletions, or duplications, were not detected in blood or skeletal muscle." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="11667" end="11673" sStart="null" offset="55" sid="r10.common.j.0742" wn="3" wnkey="common%5:00:00:shared:00" text="Both mother and child were found to have two common polymorphisms in homoplasmic state, G185A and A73G." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2431-2-12.anc" start="17588" end="17595" sStart="null" offset="155" sid="r11.absence.n.0657" wn="1" wnkey="absence%1:26:00::" text="Barth syndrome, a cause of 3-MGC aciduria and cardiomyopathy, would be an unlikely diagnosis in our patient primarily due to absence of symptoms in female carriers secondary to presumed skewing of X-inactivation and lack of growth retardation and neutropenia." />
  </sentences>
</list>